// App-Quantinova.ai

: Refractory Immune Mediated ITP in a Patient with Metastatic Melanoma

Researchers

Presenter

  • Farah Shaukat

Principal Investigators

  • Roopa Gupta

  • Hira Latif

Medical Centers

  • Bay Hematology Oncology, Easton, MD

  • University of Maryland, Baltimore, MD

  • Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Musculoskeletal

Disease

  • Thrombotic microangiopathy

  • Melanoma

  • Thrombocytopenia

  • Chronic obstructive pulmonary disease

Biomarkers

  • B-Raf proto-oncogene, serine/threonine kinase

Drug/Treatment

  • Immune globulin

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Romiplostim

  • Ipilimumab

  • Nivolumab

  • Rituximab

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved